Effect of curcumin in cigarette smokers

Phase 2

• Conditions: icotine dependence in cigarette smokers.; Nicotine dependence, cigarettes; F17.21

• Registration Number: IRCT20170420033551N12
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

Smoking dependence (Fagerstrom test score more than 4)
Age of 17 to 50 years old
Complete informed consent

Exclusion Criteria

Unwillingness to cooperate
Taking curcumin, anti-inflammatory and antioxidant supplements during the last 3 months before the intervention.
History of metabolic diseases including diabetes, hypertension, thyroid, and cardiovascular disease.
Pregnant women
Positive urine test for morphine, methamphetamine and cannabis
Use of psychiatric and neurological drugs such as benzodiazepines and antidepressants

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
icotine Dependence Syndrome Scale. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.;Depression beck score. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.;Anxiety beck score. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: Questionnaire.